M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Survey of Cancer Patients' Perceptions of Difficulties Encountered When Filling Opioid Prescriptions

Conditions: Malignant Neoplasm
Pain

Interventions: Other: Medical Chart Review
Other: Survey Administration

First Posted Date: 2019-06-18

Last Posted Date: 2020-05-29

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 140

Registration Number: NCT03989128

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Itacitinib and Alemtuzumab in Treating Patients With T-Cell Prolymphocytic Leukemia

Phase 1

Completed

Conditions: Recurrent T-Cell Prolymphocytic Leukemia
T-Cell Prolymphocytic Leukemia

Interventions: Biological: Alemtuzumab
Drug: Itacitinib

First Posted Date: 2019-06-18

Last Posted Date: 2024-10-10

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 15

Registration Number: NCT03989466

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer

Phase 3

Recruiting

Conditions: Stage I Prostate Cancer AJCC v8
Stage II Prostate Cancer AJCC v8
Stage IVA Prostate Cancer AJCC v8
Stage III Prostate Cancer AJCC v8

Interventions: Radiation: Hypofractionated Radiation Therapy
Other: Quality-of-Life Assessment
Radiation: Radiation Therapy
Other: Questionnaire Administration

First Posted Date: 2019-06-17

Last Posted Date: 2024-05-16

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 178

Registration Number: NCT03987386

Locations: 🇺🇸
MD Anderson League City, League City, Texas, United States
🇺🇸
MD Anderson in Sugar Land, Sugar Land, Texas, United States
🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Ultrasound in Evaluating Muscle-Glycogen Content in Cancer Patients

Not Applicable

Active, not recruiting

Conditions: Cachexia
Malignant Solid Neoplasm

Interventions: Procedure: Physical Therapy
Other: Questionnaire Administration
Procedure: Ultrasound

First Posted Date: 2019-06-11

Last Posted Date: 2024-10-16

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 21

Registration Number: NCT03982082

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

New Magnetic Resonance Imaging and Spectroscopy Software in the Improvement of Image Quality

Not Applicable

Completed

Conditions: Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm

Interventions: Procedure: Magnetic Resonance Imaging
Procedure: Magnetic Resonance Spectroscopic Imaging

First Posted Date: 2019-06-10

Last Posted Date: 2022-10-28

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 273

Registration Number: NCT03980535

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Time From Onset of Fever to Administration of Antibiotics in Neutropenic Fever Patients

Completed

Conditions: Fever
Febrile Neutropenia

Interventions: Other: Interview
Other: Survey Administration

First Posted Date: 2019-05-30

Last Posted Date: 2023-07-21

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 315

Registration Number: NCT03968328

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

Phase 1

Recruiting

Conditions: Recurrent Fallopian Tube Carcinoma
Recurrent Ovarian Carcinoma
Recurrent Primary Peritoneal Carcinoma
Recurrent Vaginal Carcinoma
Stage IV Cervical Cancer AJCC v8
Stage IV Fallopian Tube Cancer AJCC v8
Stage IVB Ovarian Cancer AJCC v8
Recurrent Cervical Carcinoma
Stage IV Uterine Corpus Cancer AJCC v8
Stage IVA Vaginal Cancer AJCC v8

Interventions: Other: Quality-of-Life Assessment
Radiation: Radiation Therapy
Drug: Talazoparib

First Posted Date: 2019-05-30

Last Posted Date: 2024-08-26

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 24

Registration Number: NCT03968406

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
🇺🇸
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States

An Investigational Scan (MRI) in Imaging Patients with Newly-Diagnosed or Recurrent Thymoma

Not Applicable

Active, not recruiting

Conditions: Recurrent Malignant Thymoma
Thymoma

Interventions: Procedure: Diaphragm Fluoroscopy
Procedure: Magnetic Resonance Imaging

First Posted Date: 2019-05-30

Last Posted Date: 2024-10-03

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 40

Registration Number: NCT03968315

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

PET/MR Versus CECT Scans in Imaging Patients with Ovarian Cancer or Highly Suspected Ovarian Cancer

Not Applicable

Active, not recruiting

Conditions: Malignant Ovarian Neoplasm
Ovarian Carcinoma

Interventions: Radiation: Dynamic Enhanced CT
Procedure: Magnetic Resonance Imaging
Procedure: Positron Emission Tomography

First Posted Date: 2019-05-29

Last Posted Date: 2024-10-17

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 21

Registration Number: NCT03965481

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Nurse-Driven Telephone Intervention in Improving Side Effects in Cancer Patients Undergoing Chemotherapy

Not Applicable

Completed

Conditions: Head and Neck Carcinoma
Sarcoma
Breast Carcinoma

Interventions: Other: Survey
Other: Survey Administration
Behavioral: Telephone-Based Intervention

First Posted Date: 2019-05-28

Last Posted Date: 2019-12-24

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 90

Registration Number: NCT03964896

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy